Bioquell to Exhibit at IPC London 2019

Bioquell is a well-established global leader in the design and manufacture of high performance bio-decontamination solutions for risk reduction within the healthcare, life science and pharmaceutical industries. The UK-based company operates worldwide through its own sales offices and international distributor network.

Bioquell's validated and compliant Hydrogen Peroxide Vapour technology is used across the world to eradicate airborne biological contaminants including problematic bacteria, viruses and fungi on every exposed surface in any suitable enclosure to ensure maximum uptime. Deployment of Bioquell's Hydrogen Peroxide Vapour process provides residue-free, safe and repeatable disinfection of rooms, buildings, equipment and sensitive electronics. By eliminating 99.9999% of pathogens for a 6-log kill, it is a clear alternative to traditional methods such as formaldehyde or chlorine-based products.

Bioquell’s Hydrogen Peroxide Vapour, range of scalable systems, high quality consumables and expert services enable companies to work more productivity, manage risks to patients or workspaces and reduce operating costs.

More about Bioquell (UK) Ltd

 

Other news

Upcoming Events

BSA Annual Conference 2019: Translating Research into Practice

Molineux Stadium, Wolverhampton
Wednesday 5th June

Sepsis + Conference 2019

National Conference Centre Birmingham
11th June

Knowlex: Patient Safety 2019

NCC Birmingham
11th June 2019

BSG Annual Meeting 2019

Glasgow
Monday 17th June to Thursday 20th June 2019

AfPP Residential 2019

York University
8th to the 11th August

Latest Issue

Clinical Services Journal

Clinical Services Journal

May 2019

Improving safety for both staff and patients

Register now to apply for regular copies of Clinical Services Journal and free access to premium content, as well as our regular newsletters.

CSJ Supplements

CSJ Supplements

Apr 2019

Putting patients and hospitals first

Register now to apply for regular copies of CSJ Supplements and free access to premium content, as well as our regular newsletters.